💊

Drugs Recalls

Prescription and over-the-counter medications

17,685 Total Recalls

Lack of Assurance of Sterility: Firm received fentanyl from a supplier who recalled it because fliptop vial crimps were loose or missing.

Jun 27, 2014 Prescription Drugs View Details →

Failed Dissolution Specifications: Dissolution failures found during testing of control samples at the four hour time point.

Jul 24, 2014 Prescription Drugs Nationwide View Details →

Lack of Assurance of Sterility: Firm received fentanyl from a supplier who recalled it because fliptop vial crimps were loose or missing.

Jun 27, 2014 Prescription Drugs View Details →

Lack of Assurance of Sterility: Firm received fentanyl from a supplier who recalled it because fliptop vial crimps were loose or missing.

Jun 27, 2014 Prescription Drugs View Details →

Labeling: Label Error on Declared Strength; The outer light protective bags, where the ephedrine sulfate injection syringes are stored, were mislabeled with 25 mg/mL in big font and 5 mg/mL in small font, however, the actual syringes were correctly labeled as 25 mg/5 mL.

May 16, 2014 Prescription Drugs Nationwide View Details →

Lack of Assurance of Sterility: Firm received fentanyl from a supplier who recalled it because fliptop vial crimps were loose or missing.

Jun 27, 2014 Prescription Drugs View Details →

Lack of Assurance of Sterility: Firm received fentanyl from a supplier who recalled it because fliptop vial crimps were loose or missing.

Jun 27, 2014 Prescription Drugs View Details →

Presence of Particulate Matter: A glass defect was found on the interior neck of the vial during a retain sample inspection where the glass vial contained visible embedded metallic particulate and free floating metallic particulates were also found in solution.

Apr 2, 2014 Prescription Drugs Nationwide View Details →

Presence of Particulate Matter: identification of particulates in a retention sample that have been identified as a mixture of the amino acid leucine and inorganic material (containing iron, silicone and chlorine).

Aug 4, 2014 Prescription Drugs Nationwide View Details →

Marketed Without an Approved NDA/ANDA: Bacai, Inc. DBA Ky Duyen House is voluntarily recalling Lite Fit USA, lot 13165, due to undeclared sibutramine, making it an unapproved new drug.

Apr 30, 2014 Other Drugs View Details →